1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers is sponsored by Food and Drug Administration (FDA). This funding opportunity supports new approaches to facilitate therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers.
The program encourages studies to improve therapeutic development in ultra-rare cancers with high unmet medical need where there is little economic incentive for commercial entities to conduct the research. The FDA Oncology Center of Excellence (OCE) aims to advance the development and regulation of oncology products for patients with cancer.
The Pediatric Oncology Program and Rare Cancers Program were established to facilitate and expedite drug development for pediatric and other rare cancers. OCE's Project Catalyst connects scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation.
Get alerted about grants like this
Save a search for “Food and Drug Administration (FDA)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; For-profit organizations other than small businesses; State governments; County governments; City or township governments; Special district governments; Public housing authorities/Indian housing authorities; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Private institutions of higher education; Independent school districts. Confirm the full requirements in the official notice before applying.
The current listing shows $1,500,000 (Estimated Total Program Funding). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 15, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers is funded by Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The FAS NOFO opens $226M for five-year, $28–35M cooperative agreements with a July 6 deadline. The seven-country priority list — Bangladesh, Bolivia, Ecuador, Morocco, the Philippines, Sri Lanka, Thailand — replaces the prior Africa-heavy footprint with an Indo-Pacific and Western-Hemisphere geography that maps directly to U.S. commercial agriculture export strategy.
Read articleThe Agricultural Marketing Service's Regional Food System Partnerships FY2026 NOFO closes June 5, 2026 with $4.71 million for planning and implementation grants. In a year of cancelled local food programs, RFSP is the surviving piece of USDA's regional coordination strategy.
Read articleARPA-H PROSPR program funds seven research teams testing rapamycin, semaglutide, and novel compounds to extend healthspan. A deep analysis of the science, the money, and what it means for the field.
Read article